(Q43274153)
Statements
1 reference
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis (English)
1 reference
William J Sandborn
1 reference
Brian G Feagan
1 reference
Stephen B Hanauer
1 reference
Bruce Yacyshyn
1 reference
Milan Lukas
1 reference
Jaroslaw Regula
1 reference
Elena Belousova
1 reference
Njegica Jojic
1 reference
Piotr Krzeski
1 reference
Chyon-Hwa Yeh
1 reference
Christi A Messer
1 reference
18 September 2009
1 reference
1 reference
137
1 reference
6
1 reference
1934-43.e1-3
1 reference
Identifiers
1 reference
1 reference